|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
New DDP-4 Inhibitor Shows Safety, Efficacy in Type 2 Diabetes
|
|
|
Almost half of patients with type 2 diabetes poorly controlled with diet and exercise or other antidiabetic agents were able to reach target hemoglobin A1C levels of less than 7.0% with a new, highly selective dipeptidyl peptidase-IV (DDP-4) inhibitor, alogliptin (SYR-32, Takeda Pharmaceutical Co.). Reuters Health Information
|
| 3. |
Tomato Protein Reduces Atherogenesis in Mouse Model
|
|
|
Esculeogenin A, a glycoside contained in tomatoes, reduces hyperlipidemia and atherosclerosis by inhibiting acyl-coenzyme A: cholesterol acyl-transferase (ACAT), according to a report in the November issue of Arteriosclerosis, Thrombosis, and Vascular Biology. Reuters Health Information
|
|
|
